Funding Chaos May Unravel Decades of Biomedical Research
- A political battle over higher education funding, initiated by the Trump administration, has jeopardized critical tuberculosis (TB) research led by Harvard UniversityS Dr.
- The administration's October 20 deadline for colleges to agree to the compact faced immediate resistance.
- Sarah Spreitzer, vice president and chief of staff for government relations for the American Council on Education, warns the compact "seems to be trying to federalize our system...
Political Interference Threatens Tuberculosis Research and Scientific Funding
A political battle over higher education funding, initiated by the Trump administration, has jeopardized critical tuberculosis (TB) research led by Harvard UniversityS Dr. Julia Murray. The administration’s push for a new “compact” with colleges, demanding changes to governance, international enrollment, and tuition policies, has sparked widespread concern among academic institutions and scientific organizations.
The Administration’s Compact and Institutional Opposition
The administration’s October 20 deadline for colleges to agree to the compact faced immediate resistance. MIT President Sally Kornbluth wrote to U.S. Education Secretary Linda McMahon, arguing the premise of the document fundamentally contradicts the principle of merit-based scientific funding.New College of Florida, however, announced its intention to embrace the administration’s vision.
Sarah Spreitzer, vice president and chief of staff for government relations for the American Council on Education, warns the compact “seems to be trying to federalize our system of higher education and threaten academic freedom.” She questions tying grant funding to non-scientific factors like governance structure and tuition caps, asking, “How is that tied to your scientific capability?” Spreitzer fears this sets a precedent for future administrations to impose political control over higher education and science.
impact on Dr. Murray’s Tuberculosis Research in Peru
Dr. Murray’s NIH-funded research focuses on the genetics and metabolism of TB, its spread, and potential treatments, with a significant portion conducted in Peru, where TB rates are dramatically higher than in the U.S. In 2023, Peru experienced 173 cases per 100,000 people, compared to just 3 per 100,000 in the United States (World Bank data).
The Peruvian project, described by Johns Hopkins’ Dr. Richard Chaisson as “a very vital, influential and high-value study,” has yielded insights directly applicable to outbreaks in the U.S., such as a recent outbreak in Kansas that infected 178 people. Diagnostic and treatment tools used in Kansas were initially studied overseas.
irreplaceable Samples at Risk
Murray’s research involves a ample investment in sample collection – approximately 18,000 participants have contributed blood, saliva, and bacteria samples, stored in a specialized lab in Lima operated by Socios En Salud (Partners in Health’s Peruvian arm). This lab was already facing funding cuts from the U.S. Agency for International Development. A supplemental NIH grant of just over $400,000 was intended to recontact 1,000 previously cured patients for follow-up studies.
The goal is to use CT scans and other advanced procedures to determine which patients experience lasting lung damage, and to correlate this with genetic data and biomarkers. The urgency stems from the risk of losing contact with participants and the high cost of maintaining the sample freezers. Without funding, researchers and healthcare workers could face layoffs.
Maryline Bonnet, a medical epidemiologist at the French National Research Institute for Enduring Development, emphasizes the importance of studying TB’s long-term effects, noting that approximately 50% of cured patients experience ongoing lung disease impacting their quality of life.
Scrambling for option Funding and Broader Economic implications
Throughout 2025, Dr. murray actively sought alternative funding from private donors and non-governmental organizations to prevent the loss of resources. Though, matching NIH’s investment proved difficult, and securing funding for international research is increasingly challenging.
Stephen Carpenter, an infectious diseases physician at Case Western Reserve University, warns that cuts to NIH funding could have significant economic consequences. A 2024 report by United for Medical Research found that each dollar NIH spends generates $2.56 in economic activity (United for Medical Research report). Proposed cuts could eliminate 40% of this activity and slow the development of new treatments.
Carpenter also fears a “huge loss” of talent as scientists may be drawn to opportunities in China or Europe.
A Personal Toll
Dr. Murray expressed feeling personally targeted by the administration’s actions, despite her dedication to global health. She believes she would be viewed as a caring physician, but fears being labeled an “elitist university professor” by the administration. She emphasizes their commitment to being “good global citizens” and finds it “weird to be told that we’re evil because we’re doing those things.”